Chromosome 7p11.2 (EGFR) variation influences glioma risk.

@article{Sanson2011Chromosome7,
  title={Chromosome 7p11.2 (EGFR) variation influences glioma risk.},
  author={M. Sanson and F. Hosking and S. Shete and D. Z{\'e}l{\'e}nika and Sara E Dobbins and Yussanne Ma and V. Enciso-Mora and A. Idbaih and J. Delattre and K. Hoang-Xuan and Y. Marie and B. Boisselier and C. Carpentier and Xiao-wei Wang and A. D. Di Stefano and M. Labussi{\`e}re and K. Gousias and J. Schramm and A. Boland and D. Lechner and I. Gut and G. Armstrong and Yanhong Liu and Robert K. Yu and C. Lau and M. C. Di Bernardo and Lindsay B. Robertson and K. Muir and S. Hepworth and A. Swerdlow and M. Schoemaker and H. Wichmann and Martina M{\"u}ller and S. Schreiber and A. Franke and S. Moebus and L. Eisele and A. F{\"o}rsti and K. Hemminki and M. Lathrop and M. Bondy and R. Houlston and M. Simon},
  journal={Human molecular genetics},
  year={2011},
  volume={20 14},
  pages={
          2897-904
        }
}
While gliomas are the most common primary brain tumors, their etiology is largely unknown. To identify novel risk loci for glioma, we conducted genome-wide association (GWA) analysis of two case-control series from France and Germany (2269 cases and 2500 controls). Pooling these data with previously reported UK and US GWA studies provided data on 4147 glioma cases and 7435 controls genotyped for 424 460 common tagging single-nucleotide polymorphisms. Using these data, we demonstrate two… Expand
Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility
TLDR
This study identified one new risk‐associated locus for glioma on chromosome 12p11.23 and demonstrated two novel association between the gliomas risk region marked by variant rs10842893 and rs4774756) andglioma risk. Expand
Deciphering the 8q24.21 association for glioma.
TLDR
To improve marker density across the 700 kb region, imputed genotypes using 1000 Genomes Project data and high-coverage sequencing data generated on 253 individuals revealed an imputed low-frequency SNP rs55705857 which was sufficient to fully capture the 8q24.21 association. Expand
Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor
TLDR
It is hypothesize that some of the established glioma risk variants induce aberrant DNA methylation in the developing tumor, either locally (gene-specific) or globally (genome-wide). Expand
Adult Diffuse Glioma GWAS by Molecular Subtype Identifies Variants in D2HGDH and FAM20C.
TLDR
Performing a genome-wide association study by molecular subtype identified two new regions, and a candidate independent region near RTEL1, that were associated with specific glioma molecular subtypes. Expand
Genome-wide association study of glioma and meta-analysis
TLDR
These findings suggest that larger studies focusing on novel approaches as well as specific tumor subtypes or subgroups will be required to identify additional common susceptibility loci for glioma risk, and that the 85 most promising single nucleotide polymorphism (SNP) markers identified in this study were examined in three replication sets. Expand
CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.
TLDR
It is suggested that pediatric and adult brain tumors might share common genetic risk factors and similar etiological pathways. Expand
Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer
TLDR
A combined analysis identified a promising susceptibility locus mapping to 1q24.1 marked by the imputed SNP rs3845536 that represents a potential risk locus for RCC, and future replication analyses are required to substantiate this observation. Expand
Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case–Control Study
TLDR
The results indicate that the risk variants that were confirmed by this study are truly associated with glioma risk and may, consequently, affect gliomagenesis and indicate the need for further studies to clarify the role of gliomas risk loci with respect to prolonged survival versus etiology. Expand
Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility
TLDR
These studies reveal the functional landscape of the 11q23.3glioma susceptibility locus and identify a network of functional SNPs in regulatory elements and two target genes as a possible mechanism driving glioma risk association. Expand
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
TLDR
A new SNP associated with glioma risk, rs1920116 (near TERC), is identified in a meta-analysis of genome-wide association studies of high-grade gliomas and replication data, which implicates telomerase in gliomagenesis. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility
TLDR
A principal component–adjusted genome-wide association study of 275,895 autosomal variants among 692 adult high-grade glioma cases and 3,992 controls found that two SNPs had the same direction of association in discovery and replication phases. Expand
Genome-wide association study identifies five susceptibility loci for glioma
TLDR
Meta-analysis of two genome-wide association studies by genotyping 550K tagging SNPs shows that common low-penetrance susceptibility alleles contribute to the risk of developing glioma and provide insight into disease causation of this primary brain tumor. Expand
Genetic Risk Profiles Identify Different Molecular Etiologies for Glioma
TLDR
These data show that genetic variations at these loci have subtype-specific effects on the risk of developing glioma, and provide novel insight into etiologic pathways in the different gliomas subtypes. Expand
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
TLDR
Observations indicate the presence of at least two independent loci within 8q24 that contribute to prostate cancer in men of European ancestry, and it is estimated that the population attributable risk of the new locus, marked by rs6983267, is higher than the locus marked byrs1447295. Expand
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
TLDR
IDH1 mutations are a strong predictor of a more favorable prognosis and a highly selective molecular marker of secondary glioblastomas that complements clinical criteria for distinguishing them from primary gliOBlastomas. Expand
Inherited variation in immune genes and pathways and glioblastoma risk
TLDR
These findings represent the first systematic description of immune genes and pathways that characterize glioblastoma risk, and a subset of 6029 SNPs in 893 genes from 531 cases and 1782 controls from MD Anderson (MDA). Expand
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
TLDR
A multivariate analysis based on a Cox model shows that age, WHO grade and genomic type provide complementary prognostic informations and highlights the potential of a whole‐genome analysis as an additional diagnostic in cases of unclear conventional genetic findings. Expand
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
  • M. Sanson, Y. Marie, +8 authors J. Delattre
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2009
TLDR
This study indicates that IDH1 codon 132 mutation is closely linked to the genomic profile of the tumor and constitutes an important prognostic marker in grade 2 to 4 gliomas. Expand
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
TLDR
Four SNPs in intron 2 of FGFR2 (which encodes a receptor tyrosine kinase and is amplified or overexpressed in some breast cancers) that were highly associated with breast cancer were identified and confirmed in 1,776 affected individuals and 2,072 controls from three additional studies. Expand
Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma
TLDR
EGFR extracellular domain mutations are the first genomic abnormalities associated with gender in primary glioblastomas, although a link between mutations of the EGFR tyrosine kinase domain and gender has been previously made in lung cancer. Expand
...
1
2
3
...